期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

血清总胆红素水平与冠脉支架植入术后再狭窄的关系 被引量：5

暂未订购
导出
摘要 目的:探讨血清总胆红素水平与冠状动脉支架内再狭窄的相关性。方法:对2005年2月至2010年8月在我院行冠脉支架植入术后1年行冠状动脉造影随访的797例患者的资料进行回顾性分析,以支架植入段内径狭窄≥50%为再狭窄,分为再狭窄组(153例)和对照组(644例),分析两组患者的临床资料、临床生化指标及冠脉造影结果的差异,探讨血清总胆红素水平和支架内再狭窄的关系。结果:再狭窄组总胆红素水平低于对照组,差异有统计学意义(P=0.008)。多因素Logistic回归分析显示:尿酸、糖尿病与再狭窄呈正相关(P<0.05)。支架直径、血清总胆红素水平与再狭窄呈负相关(P<0.05)。结论:血清总胆红素水平与冠状动脉支架内再狭窄密切相关,高血清总胆红素浓度水平是冠脉支架术后再狭窄的保护因素。
作者 刘房春 张春晓 齐向前
机构地区 天津医科大学心血管病临床学院泰达国际心血管病医院心内科
出处 《实用医学杂志》 CAS 北大核心 2012年第23期3932-3934,共3页 The Journal of Practical Medicine
关键词 冠心病 支架植入术 再狭窄 总胆红素
分类号 R541.4 [医药卫生—心血管疾病]
  • 相关文献

参考文献12

  • 1王效增,韩雅玲.冠状动脉介入术后再狭窄的药物防治[J].心血管康复医学杂志,2005,14(2):190-192. 被引量：14
  • 2Pendyala L, Jabara R, Shinke T, el al. Drug-eluting stents present and future [J]. Cardiovasc Hematol Agents Med Chem, 2008,6(2) : 105-115.
  • 3Colombo A, Hall P, Nakamura S, et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance [J]. Circulation, 1995,91(6) : 1676-1688.
  • 4Serruys P W, Unger F, Sousa J E, et al. Comparison of coronary artery bypass surgery and stenting for the treatment of muhivessel disease [J]. N Engl J Med, 2001,344(15):1117-1124.
  • 5Weintraub W S, Ghazzal Z M, Douglas J S Jr, et al. Long- term clinical follow-up in patients with angiographic restudy after successful angioplasty [J]. Circulation, 1993,87 (3): 831-840.
  • 6王超权,徐耕,程刚,王翔,任品芳.冠状动脉支架植入术后再狭窄与临床血清学指标的关系探讨[J].心脑血管病防治,2009,9(2):84-86. 被引量：14
  • 7Schwertner H A, Jackson W G, Tolan G. Association of low serum concentration of biliruhin with increased risk of coronary artery disease [ J ]. Clin Chem, 1994,40( 1 ) : 18-23.
  • 8冯国勤,杨进,王新宝,孟春,林灵丹,吴汉利.老年人血清胆红素水平与冠状动脉病变程度的关系[J].中国动脉硬化杂志,2007,15(4):311-312. 被引量：6
  • 9Kuwano T, Miura S, Shirai K, et al. Serum levels of bilirubin as an independent predictor of coronary in-stent restenosis: a new look at an oid molecule [J]. Atheroscler Thromb, 2011, 18(7) :574 -$83.
  • 10Cao G, Alessio H M, Cutler R G. Oxygen radical absorbance capacity assay for antioxidants [J]. Fre Rad Boil Med, 1993, 14(3) :303-311.

二级参考文献27

  • 1Ulus T, Yildirir A, Demirtas S, et al. Serum gamma-glutamyl transferase activity: a new marker for stent restenosis[J]? Atherosclerosis, 2007,195: 348 - 353.
  • 2Zahn R, Hamm CW, Schneider S, et al. Incidence and predictors of target vessel revase-ularization and clinical event rates of the sirolimus-elufing coronary stent[J]. American Journal of Cardiology, 2005,95:1302 - 308.
  • 3Holmes KW, Kwiterovich PO. Treatment of dyslipidemia in children and adolescente[J]. Curr Cardiol Rep,2005,7(6) :445 - 456.
  • 4Nakao A, Murase N, Ho C, et al. Biliverdin administration prevents the formation of intimal hyperplasia induced by vascular injury[J]. Circulation, 2005,112(4) :587 - 591.
  • 5St Claire DA Jr, King SB 3rd. Effect of diabetes mellitus on outcome after percutaneous transluminal coronary angioplasty[J]. Corou Artery Dis, 1996, 7: 744 - 752.
  • 6Freedman DS, Williamson DF, Gunter EW, et al. Relation of serum uric acid to mortality and ischemic heart disease. The NHANES Ⅰ Epide-miologic Follow up Study[J]. Am J Epidemiol, 1995,141:637 - 644.
  • 7Nishioka T.The incidence and mechanism of restenosis after PTCA[J].Nippon Rinsho,2003,61(Suppl 4):511-517.
  • 8Williams DO,Holubkov R,Yeh W,et al.Percutaneous coronary intervention in the current era compared with 1985-1986: the National Heart,Lung,and Blood Institute Registries[J].Circulation,2000,102(24):2910-1914.
  • 9Gruentzig AR,King SB,Schlumpf M,et al.Long-term follow-up after percutaneous transluminal coronary angioplasty.The early Zurich experience[J].N Engl J Med,1987,316(18):1127.
  • 10Park SW,Lee CW,Kim HS,et al.Comparsion of cilostazol versus ticlopidine therapy after stent implantation[J].Am J Cardiol,1999,84(5):511-514.

共引文献31

同被引文献55

  • 1中华人民共和国卫生部.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002.115-119.
  • 2Bauters C, Isner JM. The biology of restenosis[J]. Progressin Cardiovascular Disease, 2007, 40: 107-116.
  • 3Gada H, Kirtane AJ, Newman W. 5-year results of a randomized comparison of XIENCE V everolimus-eluting and TAXUS Paclitaxel-eluting stents: final results from the SPIRIT III trial (clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions)[J].JACC Cardiovasc Interv, 2013,6(12):1263-1266.
  • 4Dimopoulos K, Dudek D, Piscione F, et al. Timing of e- vents in STEMI patients treated with immediate PCI or standard medical therapy: Implications on opfimisadon of timing of treatment from the CARESS-in-AMI trial [ J ]. Int J Cardiol, 2012, 154 (3) : 275-281.
  • 5Cheng YT, Liu TJ, Lai HC, et al. Lower serum triglyceride level is a risk factor for in-hospital and late major adverse events in patients with ST-segment elevation myocardial in- farction treated with plimary percutaneous coronary inter- vention-a cohort study[ J]. BMC Cardiovasc Disord, 2014, 14 : 143.
  • 6Shih C J, Chu H, Chao PW, et al. Long-term clinical out- come of major adverse cardiac events in survivors of infective endocarditis: a nationwide population-based study [J]. Circulation, 2014, 130 (19): 1 684-691.
  • 7Gsior M, Stasik-Pres G, Pres D, et al. Relationship between blood glucose on admission and prognosis in patients with acute myocardial infarction treated with pereu- taneous coronary intervention [ J]. Kardiol Pol, 2007, 65 (9) : 1 031-038.
  • 8Tang B, Zhong Z, Shen HW, et aL Intermedin as a prog- nostic factor for major adverse cardiovascular events in pa- tients with ST-segment elevation acute myocardial infarction [J]. Peptides, 2014, 58: 98-102.
  • 9Wilson SR, Sabatine MS, Wiviott SD, et al. Assessment of adiponectin and the risk of recurrent cardiovascular events in patients presenting with an acute coronary syndrome: ob- servations from the Pravastatin Or atorVastatin Evaluationand Infection Trial-Thrombolysis in Myocardial Infarction 22(PROVE IT-TIMI 22) [J]. Am Heart J, 2011, 161 (6) : 1 147-155.
  • 10Oda E, Kawai R. A possible cross-sectional association of serum total bilirubin with coronary heart disease and stroke in a Japanese health screening population[ J ]. Heart Ves- sels, 2012, 27 (1): 29-36.

引证文献5

二级引证文献24

实用医学杂志
2012年 第23期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部